By Dave Sebastian

 

AbbVie Inc.'s Allergan Aesthetics will buy Soliton Inc. for about $550 million including debt, giving Allergan Aesthetics Soliton's Rapid Acoustic Pulse platform for improvement in appearance of cellulite in the buttocks and thighs.

At $22.60 a share in cash, the deal values Soliton at a 26% premium over its closing price Friday. The acquisition supports Allergan Aesthetics' body-contouring treatment portfolio, the companies said Monday.

Resonic, the Rapid Acoustic Pulse device, has received a Food and Drug Administration clearance for use in conjunction with laser for tattoo removal, the companies said.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

May 10, 2021 09:07 ET (13:07 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more AbbVie Charts.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more AbbVie Charts.